Table 1.
HC (n = 13) | PD-NC (n = 14) | PD-MCI (n = 13) | P-value | Pcorr (Bonferroni corrected) | ||||
---|---|---|---|---|---|---|---|---|
PD-NC VS.PD-MCI | PD-NC VS. HC | PD-MCI VS. HC | ||||||
Age a | 63.00 (8.76) | 60.00 (9.20) | 65.23 (10.96) | 0.379 | 0.506 | >1.000 | >1.000 | |
Sexb | F | 10 | 4 | 4 | 0.019 (7.943) | −0.901 (0.016)1 | −0.012 (6.312)2 | −0.018 (5.571)3 |
M | 3 | 10 | 9 | |||||
BMIa | 22.67 (2.06) | 22.63 (2.52) | 22.74 (2.62) | 0.993 | >1.000 | >1.000 | >1.000 | |
Educationa | 10.46 (3.53) | 13.93 (2.62) | 9.08 (4.46) | 0.046 | 0.048 | >1.000 | 0.242 | |
ADLa | 14.00 (0.00) | 16.36 (4.24) | 19.77 (10.86) | 0.099 | 0.577 | >1.000 | 0.101 | |
MMSEa | 28.54 (1.56) | 28.00 (1.67) | 26.38 (2.40) | 0.014 | 0.087 | >1.000 | 0.016 | |
MoCAa | 27.23 (1.53) | 26.07 (1.77) | 20.08 (2.43) | <0.001 | <0.001 | 0.391 | <0.001 | |
Wexner scorea | 3.92 (2.99) | 8.92 (2.02) | 8.46 (1.98) | <0.001 | >1.000 | <0.001 | <0.001 | |
Durationc | – | 5.64 (3.34) | 7.00 (8.07) | 0.568 (0.579) | ||||
H-Y stagec | – | 1.89 (0.49) | 1.80 (0.43) | 0.637 (−0.478) | ||||
MDS-UPDRS IIIc | – | 30.07 (14.01) | 30.08 (14.40) | 0.999 (0.001) | ||||
PDQ-39c | – | 27.29 (19.44) | 32.46 (19.16) | 0.493 (0.696) | ||||
Anti-Parkinson medicineb | Y | – | 10 | 10 | 0.745 (0.106) | |||
N | – | 4 | 3 | |||||
COMT- inhibitorsb | Y | – | 3 | 2 | 0.686 (0.163) | |||
N | – | 11 | 11 | |||||
Alcoholb | Y | 2 | 1 | 0 | 0.329 (2.222) | |||
N | 11 | 13 | 13 | |||||
Coffeineb | Y | 6 | 4 | 2 | 0.229 (2.951) | |||
N | 7 | 10 | 11 |
Data are shown as mean (SD).
Means with One-way ANOVA. Pcorr denotes values corrected for multiple comparisons using the Bonferroni method. Alpha was set at 0.0167.
Means with Pearson's Chi-square test. 1, 2, and 3 mean difference of sex between PD-MCI and PD-NC group, PD-NC and HC group as well as PD-MCI and HC group, respectively. Alpha was set at 0.05.
Means with student's t-test. Alpha was set at 0.05.